Two phosphatidylserine quotations at the same price per kilogram can differ enormously in what they actually deliver. One is a nearly pure phospholipid concentrate; the other is phosphatidylserine standardized on a carrier — a maltodextrin or gum arabic base, or an oil paste — engineered for handling rather than for headline assay. Neither presentation is better in the abstract, but choosing the wrong one locks a programme into the wrong flow behaviour, the wrong label declaration and the wrong cost-per-active math for years. Because the carrier travels with the ingredient through blending, encapsulation, labeling and regulatory review, this is one of the few ingredient decisions that touches every function at once: purchasing, formulation, QA and marketing. This article maps the commercial presentations US and EU buyers encounter, matches each to the dosage formats it serves, works through the label and assay consequences, and closes with a checklist for the next RFQ. For orientation on where these presentations sit in the wider range, browse the phosphatidylserine grade portfolio before comparing quotations.

Why the Carrier Decision Shapes the Whole OEM Programme

The carrier is not an excipient a contract manufacturer can adjust later; it is part of the ingredient as the supplier delivers it, and it appears on the finished-product ingredient list. That single fact cascades. It sets the ceiling on active content per capsule or per scoop. It determines whether the powder flows on high-speed filling equipment or hangs in the hopper. It decides whether the label carries a soy declaration, whether a vegan claim survives, and whether the sensory profile of the finished blend stays neutral. And because switching presentations mid-programme counts as a supplier change requiring notification and requalification, a decision made casually at the quotation stage tends to persist well past its usefulness.

The Three Commercial Presentations Buyers Actually Quote

The market settles into three families. First, carrier-free paste: phosphatidylserine concentrated in its own phospholipid-and-oil matrix, typically at mid-range assays, with the cleanest composition and the highest handling burden — it is viscous, needs warming and positive displacement, and resists standard powder dosing. Second, high-assay carrier-free powder: the concentrated phospholipid fraction, often above 50% and up to 70% or more, free-flowing only with difficulty because phospholipid powders are hygroscopic and static-prone. Third, carrier-standardized powder: phosphatidylserine dispersed on a soluble base such as maltodextrin, gum arabic or modified starch, standardized to a declared active level — commonly 20%, 50% or 70% — and engineered for free flow, fast dispersion and stable blending. The trade is consistent across all three: handling simplicity and format fit on one side, assay ceiling and label simplicity on the other. The arithmetic behind that trade — cost per active point at each assay level and carrier combination — is worked through in our comparison of 20%, 50% and 70% phosphatidylserine grades, which pairs naturally with the decision framework here.

Matching the Carrier System to the Dosage Format

Format fit is where the decision is won or lost. Two-piece capsules and tablets need a powder that flows uniformly into the die or dosing disc; a carrier-standardized grade usually performs here as delivered, while a high-assay carrier-free powder may demand added glidants and careful humidity control on the filling line. Stick packs and instant powders favour soluble carriers, because the base dissolves with the active and leaves no grit. Gummies and emulsion-based formats pull toward paste or pre-emulsified presentations, where the phospholipid is already in an oil phase that integrates with the recipe. Ready-to-drink beverages behave like stick packs: soluble carriers disperse cleanly, while neat phospholipid concentrates can haze or separate. Softgel fills take either the paste directly or neat powder dispersed into the fill matrix at the filler. The governing question for every format is the same: does the presentation flow, disperse and dose the way the line expects — and if not, whose problem does that become? The practical answer is to test before committing, which is exactly what our flowability and blend-uniformity pilot protocol is designed to surface before a bulk order is placed.

Spray-drying tower and powder handling line producing phosphatidylserine ingredient powder in a modern facility

Label, Allergen and Claim Consequences

Carriers are declarations, not invisible maths. A phosphatidylserine powder on a soy-derived base imports soy into the finished label, whatever the phospholipid's own origin; a sunflower-based or gum-based system can keep an allergen statement cleaner. Vegan positioning is equally sensitive, because some carriers and oil phases are animal-derived. Concentration claims interact too: "50 mg phosphatidylserine per serving" must be supported by the standardized assay on the COA, and the carrier occupies the remaining label weight. Buyers chasing a "carrier-free" clean-label story get that simplicity at the cost of format flexibility, since the concentrated presentations are the hardest to run. The allergen dimension interacts closely with source selection, so it is worth cross-reading the sunflower-derived phosphatidylserine grades when a soy-free declaration is part of the brief.

Assay Economics and Specification Control

Carrier-standardized grades look cheaper per kilogram and frequently are more expensive per active point. The discipline is to normalize every quotation to cost per gram of declared phosphatidylserine, then weigh the handling and label consequences on top. Specification control follows the carrier into the document set as well. A carrier-bearing COA should declare not only the active assay but the carrier identity, moisture, and the microbial and contaminant limits that apply to the whole composite — because the carrier, not the phospholipid, is usually the dominant substrate for water activity and microbial growth. For pastes, surface oil and peroxide figures belong in the spec; for carrier powders, particle size and dispersion time do. A composition table that names "phosphatidylserine powder" without naming the carrier is a document to reject, not to negotiate.

Laboratory analyst measuring flow properties of phospholipid powder samples with test sieves

A Selection Checklist for the Next RFQ

Before issuing the next phosphatidylserine RFQ, fix five points in writing: the target dosage format and the equipment that will run it; the active content required per serving and the presentation that can deliver it at realistic fill weights; the label constraints — allergen declarations, vegan status, clean-label positioning — and which presentations satisfy them; the specification set the composite requires, including carrier identity, moisture, water activity and microbial limits; and the validation plan, with sample quantities reserved for flow, dispersion and blend-uniformity trials on your own line. A quotation that answers all five is a specification; one that answers none of them is a price.

Часто задаваемые вопросы

Q: Is carrier-free phosphatidylserine always the better quality choice?

A: No. Carrier-free concentrates offer the cleanest composition and the highest active ceiling, but they are harder to handle, harder to dose and harder to label around. Quality is fit for format: a well-specified 50% grade on a declared carrier can outperform a 70% carrier-free powder that hangs in the hopper and segregates in the blend.

Q: Does the carrier count as an excipient we have to list on the finished label?

A: Yes. The carrier is part of the ingredient as delivered and is declared by name in the ingredient list, and it can carry allergen declarations with it — soy-derived bases import soy. Confirm the exact carrier identity and its own origin in writing before approving artwork.

Q: Can we switch presentations after the first production run?

A: Technically yes, commercially expensively. A presentation change alters fill weight, flow behaviour and the ingredient declaration, so it triggers change control, stability retesting and usually regulatory re-checks of the label. Decide with pilot data first; treat a mid-programme switch as a requalification project.

Заключение

Carrier selection is where an OEM programme quietly commits to its flow behaviour, its label and its cost structure — long before anyone approves artwork. Decide it deliberately: match the presentation to the dosage format, normalize quotations to cost per active point, pull allergen and vegan consequences into the specification, and validate with pilot trials rather than assumptions. Nutranexa supplies soy-derived and sunflower-derived phosphatidylserine in carrier-standardized and concentrated presentations, each with a composition table that names the carrier and the full declaration set behind it — review the quality and R&D support behind those specifications and request samples of the grades that fit your format before committing volume.

Источники

  1. FDA — Food Labeling Guide (ingredient declarations)
  2. EUR-Lex — Regulation (EU) No 1169/2011 on food information to consumers, Annex II allergens
  3. FDA — Dietary Supplements: Ingredients & Labeling
  4. EUR-Lex — Regulation (EC) No 1333/2008 on food additives (carrier definitions)

Для каких покупателей

Для кого это руководство

Это руководство подготовлено для указанных ниже типов покупателей. Откройте свой профиль, чтобы увидеть подходящие марки, документы и дальнейшие шаги, или сразу сообщите нам свои требования.

Задайте вопрос по этому руководству для вашего профиля

Рекомендуемые дальнейшие действия

Свяжитесь с отделом продаж для получения документации по продукту

Поделитесь предпочтениями источника, приложением, страной и годовым количеством.

Свяжитесь с отделом продаж